You just read:

Blueprint Medicines to Present New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors at 2017 ASCO Annual Meeting

News provided by

Blueprint Medicines

May 17, 2017, 17:01 ET